December 15th, 2015

Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Donald Johns Joins Biogen Idec to Lead ALS Innovation Hub

[Business Wire] – Biogen Idec today announced that Donald R. Johns, M.D., has joined the company as vice president, leading Biogen Idec’s amyotrophic lateral sclerosis Innovation Hub . Read more on this. . . . → Read More: Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Donald Johns Joins Biogen Idec to Lead ALS Innovation Hub Similar Articles: Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Idec Names Adriana Karaboutis EVP, Technology and Business Solutions Biogen Idec Inc (NASDAQ:BIIB) | ISIS Pharmaceuticals’ and Biogen idec’s innovative collaboration voted breakthrough alliance of 2014 Market Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Idec to Present New Two-Year Data from the PLEGRIDY™ (Peginterferon Beta-1a) Phase 3 ADVANCE Study at AAN Annual Meeting
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.